Increased incidence of Graves' disease during the SARS-CoV2 pandemic.
David E Barajas GalindoBeatriz Ramos BachillerLucía González RozaJosé María García Ruiz de MoralesFernando Sánchez LasherasElena González ArnáizDiana Ariadel CoboMaría Dolores Ballesteros-PomarIsidoro Cano RodríguezPublished in: Clinical endocrinology (2022)
Our results show a notable increase in the incidence of GD during the year 2021, specially in women with a history of smoking. Hyper activation of the immune system induced by SARS-CoV2 and by the recently released SARS-COV-2 vaccines has been highlighted in recent months. To assess whether this observed increase in the incidence of GD is sustained in the coming years or has simply been a precipitous trigger for individuals who were already predisposed to develop the disease, future studies will be needed.